BTIG sees Moonlake stock as a buy, driven by sonelokimab’s market growth prospects

Tomas Kauer - Moderator

Sep 12, 2024 - 19:00

0

BTIG sees Moonlake stock as a buy, driven by sonelokimab’s market growth prospects

Tags:

Previous Article

General Mills in talks to sell North America yogurt operations to Lactalis, Sodi...

CyberArk stock gains momentum with rising demand for non&PAM solutions – DA Davi...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator www.tomaskauer.com

Related Posts

US working to keep Israel, Hamas engaged in Gaza truce efforts

US working to keep Israel, Hamas engaged in Gaza truce ...

Tomas Kauer - Mode... Jun 28, 2024 0

US prosecutors meeting with Boeing, crash victims as criminal charging decision looms, sources say

US prosecutors meeting with Boeing, crash victims as cr...

Tomas Kauer - Mode... Jul 7, 2024 0

Tikehau Capital: Disclosure of Shares Repurchases from 6 September 2024 to 12 September 2024

Tikehau Capital: Disclosure of Shares Repurchases from ...

Tomas Kauer - Mode... Sep 13, 2024 0